Investors
Overview
Niki BioSolutions is a clinical-stage life sciences company focused on unmet medical needs and high-quality genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations through its CLIA-certified, CAP-accredited laboratory. The company combines proprietary technologies with a commitment to scientific rigor to support precision medicine across a range of therapeutic areas, including neurodegeneration and other brain health conditions. Niki BioSolutions collaborates with leading academic centers, disease foundations, and biopharma companies.
Latest News
Recent Events
September 29–30, 2026 · Webcast September 29 at 12:00 p.m. ET
Lytham Partners Fall 2026 Investor Conference — Replay (opens in a new tab)
Niki BioSolutions
September 2026
H.C. Wainwright Global Investment Conference (opens in a new tab)
Niki BioSolutions
Stock Information
Investor Contacts
Investor Relations
Ben Shamsian
Lytham Partners
Transfer Agent
Continental Stock Transfer & Trust Company